Bio-Connect supports ALS research with advanced biomarkers, iPSC-derived disease models and high-quality antibodies and assays, helping Benelux labs accelerate ALS discoveries.
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, characterized by progressive motor neuron loss, limited treatment options and an urgent need for improved diagnostics and therapies.
On World ALS Day, Bio-Connect highlights how we, together with our suppliers, support ALS researchers and diagnostics developers with tools that help accelerate discovery and innovation.
By combining a strong local presence in the Benelux with a carefully curated global supplier network, Bio-Connect provides access to a wide range of ALS-relevant research solutions from biomarkers and ELISA kits to human iPSC-derived neurons and glia, and from recombinant antibodies to advanced cell culture systems.
Supporting ALS research and patient-focused innovation is an area Bio-Connect is proud to contribute to, because every new biomarker, disease model and assay contributes to a better understanding of ALS and may help bring the field closer to earlier diagnosis, improved patient stratification and more effective therapies.
Sensitive, non-invasive biomarkers are critical for monitoring disease progression, stratifying patients in clinical studies and evaluating emerging therapies in ALS. One example is Titin N-Fragment, a muscle-derived protein fragment that has been investigated as a biomarker of disease severity and prognosis in ALS. In a clinical study, urinary Titin N-Fragment levels were significantly elevated in ALS patients and correlated with ALS Functional Rating Scale (ALSFRS-R) scores, suggesting potential utility for assessing disease progression. In combination with other biomarkers, such as neurofilament light chain (NfL), urinary Titin N-Fragment may also provide prognostic information.
Through Bio-Connect, researchers in the Benelux can access the Human Titin N-Fragment (Urine) ELISA Kit from IBL, facilitating the evaluation of this biomarker in ALS research and multi-marker studies.
You can read more about this application in our news item: Urinary Titin N-fragment by IBL Japan – disease prognosis of AL
This article explores the scientific background of urinary Titin N-Fragment, reviews clinical findings in ALS and highlights its potential as a complementary biomarker alongside neurofilament light chain (NfL) for ALS research and biomarker development.
Human-relevant in vitro models are essential for understanding ALS mechanisms and evaluating new therapeutic strategies. Through our supplier BrainXell, Bio-Connect offers human iPSC-derived neurons and glia, including spinal motor neurons, spinal astrocytes, cortical neurons and microglia, generated from control, disease-specific and gene-edited iPSC lines. These cells can be used to model neurodegenerative and neuroinflammatory processes, including ALS, in both 2D cultures and more advanced 3D systems.
Our dedicated news article highlights how these cells support translational neuroscience research, disease modelling, target validation and drug discovery through more physiologically relevant in vitro systems. iPSC-Derived Human Neurons and Glia from BrainXell
For a broader overview of iPSC-powered in vitro models, including lines for neurodegenerative diseases such as ALS, you can also explore: Better in vitro models with human iPSC-derived cells
These articles highlight how human iPSC-derived neurons, astrocytes and microglia are being used to create advanced ALS disease models, providing researchers with more physiologically relevant tools for mechanistic studies, target validation and drug discovery.
In addition to BrainXell, Bio-Connect works with supplier Axol Bioscience to offer human iPSC-derived cells tailored for neuroscience and neurodegeneration research. Axol’s portfolio includes human-relevant models for diseases such as ALS, Alzheimer’s disease and Huntington’s disease, enabling more physiologically relevant in vitro systems compared to traditional immortalized cell lines or non-human models.
Learn more about these solutions in our news article: Axol Bioscience: human-relevant iPSC powered in vitro models
By combining iPSC-derived cell types such as motor neurons, astrocytes and microglia, researchers can develop advanced co-culture and organoid models that better reflect the cellular complexity of ALS, including neuroinflammatory processes and cell–cell interactions involved in disease progression.
ALS pathogenesis involves protein aggregation, excitotoxicity, axonal degeneration and neuroinflammation. To dissect these processes, researchers depend on reliable antibodies against key neuronal, glial and inflammatory markers, as well as disease-associated proteins. Through Bio-Connect, researchers have access to a broad portfolio of recombinant antibodies and related immunodetection tools to support immunohistochemistry, immunofluorescence, Western blot, flow cytometry and multiplex assays.
Our news item on recombinant antibodies explains how fully defined, engineered antibody formats improve reproducibility, consistency and experimental flexibility in demanding research applications: Tailored Confidence: Recombinant Antibodies for Research
For ALS-related studies, these tools can be combined with neural marker panels and disease-relevant targets such as SOD1, GFAP and neurofilament proteins to monitor neuronal health, glial activation and biological responses to candidate therapies.
Bio-Connect’s core mission is to connect researchers and diagnostics developers in the Benelux with high-quality products from leading life science suppliers worldwide. For ALS-focused teams, this means:
To explore the full BrainXell portfolio distributed by Bio-Connect, visit: BrainXell – supplied by Bio-Connect
By focusing on innovative products and clear scientific communication, Bio-Connect aims to reduce the time you spend searching for tools and increase the time you can dedicate to experiments that matter for people living with ALS.
On this World ALS Day, we invite you to explore our ALS-related news items and supplier pages and to discover how Bio-Connect can support your next project, whether you are validating a new biomarker, establishing an iPSC-based ALS model or developing a novel diagnostic assay.
If you would like more information or advice on selecting the right products for your experiments, please contact us or reach out to your dedicated account manager to discuss the options for your lab. Visit our news section to read the full stories and access the products highlighted in this article. By engaging with these resources, you help turn awareness into action and drive the innovations that ALS patients and their families urgently need.
We gladly support you by keeping you updated on our latest products and developments
